Epstein Secrets

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Fwd: FOURIER: Significant LDL Reduction with Evolocumab Date: Fri, 24 Mar 2017 11:18:31 +0000 Begin forwarded mes

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Fwd: FOURIER: S

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Fwd: FO

esults of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. March 17. Presented at: American College of Cardiology 2017 Scientific Session in Washington, D.C. Copyright @ 2017 American Medical Communications. All rights reserved. Our mailing address is: American Medical Communication

Mar 2017 11:17:36 +0000 Lesley please forward to Jeffrey rs Rony Shimony, M.D. F.A.C.C. Associate Profe

esults of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. March 17. Presented at: American College of Cardiology 2017 Scientific Session in Washington, D.C. Copyright C' 2017 American Medical Communications. All rights reserved. Our mailing address is: American Medical Communicatio

r 24, 2017, at 7:17 AM, Lesley please forward to Jeffrey rs Rony Shimony, M.D. F.A.C.C. Associate Profe

esults of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial. March 17. Presented at: American College of Cardiology 2017 Scientific Session in Washington, D.C. Copyright O 2017 American Medical Communications. All rights reserved. Our mailing address is: American Medical Communication